西尼地平

西尼地平

(E)-(±)-1,4-DIHYRO-2,6-DIMETHYL-4一(3-NITMPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID 2-METHOXYETHYL 3-PHENYL-2-PROPENYL ESTER;(E)-(±)-1,4一二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二羧酸2-甲氧基乙基酯3-苯基-2-丙烯基酯;西尼地平CILNIDIPINE;西尼地平;1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二羧酸2-甲氧基乙酯肉桂醇酯;西尼地平 西尼地平中间体;(±)-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二;3-肉桂基 5-(2-甲氧基乙基) 2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯

Cilnidipine

ATELEC;(+/-)-(e)-cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate;O3-(2-Methoxyethyl) O5-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid 3-(2-methoxyethyl)5-[(E)-3-phenyl-2-propenyl] ester;2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylic acid 3-(2-methoxyethyl)5-[(E)-3-phenyl-2-propenyl] ester;Frc 8653,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester;1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl Ester 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate;ilnidipine

634-350-6

C27H28N2O7

492.52

InChI=1/C27H30N2O6/c1-19-24(18-34-14-8-11-21-9-5-4-6-10-21)26(22-12-7-13-23(17-22)29(31)32)25(20(2)28-19)27(30)35-16-15-33-3/h4-13,17,26,28H,14-16,18H2,1-3H3/b11-8+

1.240±0.06 g/cm3(Predicted)

-97-99°C

652.6±55.0 °C(Predicted)

-

-

-

从甲醇结晶，熔点115.5～116.6℃。急性毒性LD₅₀雄、雌小鼠，雄、雌大鼠(mg/kg)：＞5000，＞5000，＞5000，4412 口服；全部＞5000皮下注射；1845，2353，441，426腹腔注射。

钙拮抗剂。用于降压。

-

如果接触眼睛，请立即用大量清水冲洗喝水并寻求医疗建议、佩戴眼部/面部防护用品